Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Minimal-Incision Technique With Modified Tracking Pin Placement Versus Standard Robotic-Assisted Total Knee Arthroplasty (MISI)

10 agosto 2026 aggiornato da: Jung-Il Kim, Hallym University Kangnam Sacred Heart Hospital

Comparison of a Minimal Incision and Minimal Soft-Tissue Injury (MISI) Technique Versus the Standard Technique in Robotic-Assisted Total Knee Arthroplasty: A Randomized Controlled Trial

This randomized controlled trial will compare a minimal-incision and soft-tissue-preserving (MISI) technique with the standard surgical technique in patients undergoing robotic-assisted total knee arthroplasty for knee osteoarthritis. A total of 100 participants will be randomly assigned in a 1:1 ratio to undergo either the MISI technique, which uses a reduced skin incision, limited soft-tissue dissection, and modified tracking pin placement, or the standard technique. The primary outcome is postoperative scar assessment at 3 months. Secondary outcomes include incision length, wound oozing, thigh pain and tenderness, recovery of straight-leg raising, tracking pin-related complications, patellar height, patient-reported scar assessments, and functional outcomes during follow-up.

Panoramica dello studio

Stato

Non ancora reclutamento

Condizioni

Intervento / Trattamento

Descrizione dettagliata

Robotic-assisted total knee arthroplasty requires surgical exposure and placement of tracking pins. Conventional techniques may involve a relatively long incision, broader soft-tissue dissection, and diaphyseal pin insertion. The MISI technique was developed to reduce surgical invasiveness through a shorter incision, limited soft-tissue dissection, and modified tracking pin placement that avoids diaphyseal pin insertion.

Participants will be randomly assigned to the MISI or standard technique in a 1:1 ratio. Clinical evaluations will be performed during follow-up for up to 12 months. The study will assess whether the MISI technique improves scar-related outcomes and early recovery without increasing procedure-related complications.

Tipo di studio

Interventistico

Iscrizione (Stimato)

100

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Ho-Jung Jung, MD, PhD
  • Numero di telefono: 82-02-819-5165
  • Email: hodge@hallym.or.kr

Luoghi di studio

      • Seoul, Corea del Sud
        • Hallym University Kangnam Sacred Heart Hospital
        • Contatto:

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Adults aged 18 years or older
  • Degenerative knee osteoarthritis requiring robotic-assisted total knee arthroplasty
  • Body mass index below 30 kg/m²
  • Preoperative knee flexion of 90 degrees or greater
  • Ability to understand the study information and provide written informed consent

Exclusion Criteria:

  • Skin lesions or conditions that may adversely affect wound healing
  • Previous intra-articular surgery of the affected knee
  • Inflammatory arthritis, including rheumatoid arthritis
  • Severe hepatic or renal disease associated with poor general health
  • Comorbid conditions that may substantially affect mobility, including Parkinson disease, sequelae of poliomyelitis, or stroke
  • Inability or unwillingness to complete the required follow-up
  • Any medical or other condition that, in the investigator's judgment, makes participation inappropriate

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: MISI tenchique
Participants will undergo robotic-assisted total knee arthroplasty using the minimal incision and minimal soft-tissue injury (MISI) technique. The procedure uses an approximately 10-cm main incision with limited soft-tissue dissection. Two femoral tracking pins are inserted through the main incision, and one tibial tracking pin is inserted through an additional approximately 5-mm incision.
Robot-assisted total knee arthroplasty performed using an approximately 10-cm main incision, limited soft-tissue dissection, two femoral tracking pins inserted through the main incision, and one tibial tracking pin inserted through an additional approximately 5-mm incision.
Comparatore attivo: Standard technique
Participants will undergo robotic-assisted total knee arthroplasty using the standard surgical technique. Tracking arrays are secured using the conventional pin placement method, with four tracking pins placed in the femoral and tibial regions and an additional femoral incision.
Robot-assisted total knee arthroplasty performed using the standard incision and soft-tissue exposure, with conventional placement of four tracking pins in the femoral and tibial regions and an additional femoral incision.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Patient and Observer Scar Assessment Scale Score
Lasso di tempo: 3 months after surgery
The combined Patient and Observer Scar Assessment Scale (POSAS) score is calculated by summing the total Patient Scale score and the total Observer Scale score. Each scale consists of six items rated from 1 to 10, resulting in a score of 6 to 60 for each scale and a combined score ranging from 12 to 120. Higher scores indicate poorer scar quality. The Observer Scale will be completed by an independent outcome assessor blinded to treatment allocation.
3 months after surgery

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Patient and Observer Scar Assessment Scale Score
Lasso di tempo: 3 and 6 weeks after surgery
The combined Patient and Observer Scar Assessment Scale (POSAS) score is calculated by summing the total Patient Scale score and the total Observer Scale score. Each scale consists of six items rated from 1 to 10, resulting in a score of 6 to 60 for each scale and a combined score ranging from 12 to 120. Higher scores indicate poorer scar quality. The Observer Scale will be completed by an independent outcome assessor blinded to treatment allocation.
3 and 6 weeks after surgery
Main Surgical Incision Length
Lasso di tempo: During surgery and on postoperative day 1
The length of the main surgical incision will be measured in centimeters. The initial incision length will be measured immediately after the skin incision with the knee in extension, and the final incision length will be measured before wound closure. The incision length will also be evaluated on postoperative day 1. Separate tracking pin-site incisions will not be included.
During surgery and on postoperative day 1
Intraoperative Incision Stretching Index
Lasso di tempo: During surgery
The incision stretching index is calculated as the maximum length of the main incision during knee flexion and maximal surgical retraction divided by the initial incision length measured with the knee in extension. A value of 1 indicates no stretching, and higher values indicate greater intraoperative stretching of the incision and surrounding soft tissue.
During surgery
Postoperative Gauze Oozing Grade
Lasso di tempo: Postoperative days 1, 2, 4, and 6
Postoperative wound oozing will be assessed according to the amount of blood or exudate visible on the surgical dressing using a prespecified ordinal grading scale. Higher grades indicate more extensive wound oozing.
Postoperative days 1, 2, 4, and 6
Thigh Pain at Rest on the Numeric Rating Scale
Lasso di tempo: Postoperative days 1, 2, 4, and 6
Participants will rate thigh pain at rest using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Postoperative days 1, 2, 4, and 6
Thigh Pain During Active Hip Flexion on the Numeric Rating Scale
Lasso di tempo: Postoperative days 1, 2, 4, and 6
Participants will rate thigh pain during active hip flexion while maintaining knee extension and without external resistance. Pain will be assessed using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain.
Postoperative days 1, 2, 4, and 6
Tenderness at the Standardized Tracking Pin-Site Location
Lasso di tempo: Postoperative days 1, 2, 4, and 6
Tenderness elicited by palpation at a prespecified standardized anatomical location corresponding to the tracking pin region will be rated using an 11-point numeric rating scale ranging from 0 to 10, where 0 indicates no tenderness and 10 indicates the worst imaginable tenderness.
Postoperative days 1, 2, 4, and 6
Ability to Perform Straight-Leg Raising
Lasso di tempo: Postoperative days 1, 2, 4, and 6
The participant's ability to independently raise the operated lower extremity while maintaining knee extension will be recorded as a binary outcome: able or unable to perform straight-leg raising. The number and proportion of participants able to perform the test will be compared between groups.
Postoperative days 1, 2, 4, and 6
Pain During the Resisted Straight-Leg-Raising Test
Lasso di tempo: Postoperative days 1, 2, 4, and 6
Pain during resisted straight-leg raising will be assessed using a 100-mm visual analog scale, where 0 mm indicates no pain and 100 mm indicates the worst imaginable pain.
Postoperative days 1, 2, 4, and 6
Incidence of Tracking Pin-Site Complications
Lasso di tempo: Postoperative days 1, 2, 4, and 6 and postoperative week 3
Tracking pin sites will be examined for complications, including erythema, swelling, wound drainage, infection, and pin-related fracture. The occurrence of one or more prespecified pin-site complications will be recorded as a binary outcome, and the number and proportion of participants with any complication will be reported.
Postoperative days 1, 2, 4, and 6 and postoperative week 3
Forgotten Joint Score-12
Lasso di tempo: 6 and 12 months after surgery
The Forgotten Joint Score-12 is a 12-item patient-reported questionnaire assessing awareness of the operated knee during daily activities. Scores are transformed to a scale ranging from 0 to 100, with higher scores indicating less awareness of the artificial joint and a better outcome.
6 and 12 months after surgery
Western Ontario and McMaster Universities Osteoarthritis Index
Lasso di tempo: 6 and 12 months after surgery
The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) assesses knee pain, stiffness, and physical function. The 24 items are scored using a 5-point Likert scale, producing a total score ranging from 0 to 96. Higher scores indicate more severe symptoms and poorer physical function.
6 and 12 months after surgery

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Investigatori

  • Investigatore principale: Joong-Il Kim, MD, PhD, Hallym University Kangnam Sacred Heart Hospital

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Stimato)

17 agosto 2026

Completamento primario (Stimato)

31 luglio 2027

Completamento dello studio (Stimato)

31 maggio 2028

Date di iscrizione allo studio

Primo inviato

10 agosto 2026

Primo inviato che soddisfa i criteri di controllo qualità

10 agosto 2026

Primo Inserito (Effettivo)

14 agosto 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

14 agosto 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

10 agosto 2026

Ultimo verificato

1 agosto 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • HKS 2026-05-024

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .